A review of the epidemiology and treatment of Merkel cell carcinoma

Clinics

Volumn 66, Issue 10, 2011, Pages 1817-1823

  Duprat, João Pedreira ^a   Landman, Gilles ^a,c   Salvajoli, João Victor ^b   Brechtbühl, Eduard Rene ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Carcinoma; Literature review; Merkel cell; Polyomavirus; Radiotherapy

Indexed keywords

CANCER STAGING; HUMAN; MERKEL CELL TUMOR; PATHOLOGY; REVIEW; SKIN TUMOR;

CARCINOMA, MERKEL CELL; HUMANS; NEOPLASM STAGING; SKIN NEOPLASMS;

EID: 80054725627     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322011001000023     Document Type: Review

References (64)

1. Toker C. Trabecular carcinoma of the skin. Arch Dermatol. 1972;105:107-110, doi: 10.1001/archderm.105.1.107.
2. Haag ML, Glass LF, Fenske NA. Merkel cell carcinoma. Diagnosis and treatment. Dermatol Surg. 1995;21:669-83.
3. Eng TY, Boersma MG, Fuller CD, Goytia V, Jones WE, 3rd, Joyner M, et al. A comprehensive review of the treatment of Merkel cell carcinoma. Am J Clin Oncol. 2007;30:624-36, doi: 10.1097/COC.0b013e318142c882.
4. Agelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol. 2003;49:832-41, doi: 10.1016/ S0190-9622(03)02108-X.
5. Hodgson NC. Merkel cell carcinoma: changing incidence trends. J Surg Oncol. 2005;89:1-4, doi: 10.1002/jso.20167.
6. Gupta SG, Wang LC, Penas PF, Gellenthin M, Lee SJ, Nghiem P. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: The Dana-Farber experience and meta-analysis of the literature. Arch Dermatol. 2006;142:685-90, doi: 10.1001/archderm.142.6. 685.
7. Busse PM, Clark JR, Muse VV, Liu V. Case records of the Massachusetts General Hospital. Case 19-2008. A 63-year-old HIV-positive man with cutaneous Merkel-cell carcinoma. N Engl J Med. 2008;358:2717-23, doi:10.1056/NEJMc0707784.
8. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319:1096-100, doi: 10.1126/science.1152586.
9. Miller RW, Rabkin CS. Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prev. 1999;8:153-8.
10. Pectasides D, Pectasides M, Economopoulos T. Merkel cell cancer of the skin. Ann Oncol. 2006;17:1489-95, doi: 10.1093/annonc/mdl050.
11. Kaae J, Hansen AV, Biggar RJ, Boyd HA, Moore PS, Wohlfahrt J, et al. Merkel cell carcinoma: incidence, mortality, and risk of other cancers. J Natl Cancer Inst. 2010;102:793-801, doi: 10.1093/jnci/djq120.
12. Lemos BD, Storer BE, Iyer JG, Phillips JL, Bichakjian CK, Fang LC, et al. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol. 2010;63:751-61, doi: 10.1016/j.jaad. 2010.02.056.
13. Gaudin PB, Rosai J. Florid vascular proliferation associated with neural and neuroendocrine neoplasms. A diagnostic clue and potential pitfall. Am J Surg Pathol. 1995;19:642-52, doi: 10.1097/00000478-199506000-00004.
14. Kukko H, Koljonen V, Lassus P, Tukiainen E, Haglund C, Bohling T. Expression of vascular endothelial growth factor receptor-2 in Merkel cell carcinoma. Anticancer Res. 2007;27:2587-9.
15. Falcon BL, Barr S, Gokhale PC, Chou J, Fogarty J, Depeille P, et al. Reduced VEGF production, angiogenesis, and vascular regrowth contribute to the antitumor properties of dual mTORC1/mTORC2 inhibitors. Cancer Res. 2011;71:1573-83, doi: 10.1158/0008-5472.CAN-10-3126.
16. Vazmitel M, Michal M, Shelekhova KV, Sima R, Mukensnabl P, Kazakov DV. Vascular changes in merkel cell carcinoma based on a histopathological study of 92 cases. Am J Dermatopathol. 2008;30:106-11, doi: 10.1097/DAD.0b013e318162eaa2.
17. O'Reilly KE, Rojo F, She QB, Solit D, Mills GB, Smith D, et al. mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. Cancer Res. 2006;66:1500-8, doi: 10.1158/0008-5472.CAN-05-2925.
18. Jozwiak J, Jozwiak S, Grzela T, Lazarczyk M. Positive and negative regulation of TSC2 activity and its effects on downstream effectors of the mTOR pathway. Neuromolecular Med. 2005;7:287-96, doi: 10.1385/NMM:7:4:287.
19. Becker JC, Kauczok CS, Ugurel S, Eib S, Brocker EB, Houben R. Merkel cell carcinoma: molecular pathogenesis, clinical features and therapy. J Dtsch Dermatol Ges. 2008;6:709-19, doi: 10.1111/j.1610-0387.2008.06830.x.
20. Jansen B, Heere-Ress E, Schlagbauer-Wadl H, Halaschek-Wiener J, Waltering S, Moll I, et al. Farnesylthiosalicylic acid inhibits the growth of human Merkel cell carcinoma in SCID mice. J Mol Med 1999;77:792-7, doi: 10.1007/s001099900052.
21. Boratynska M, Watorek E, Smolska D, Patrzalek D, Klinger M. Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies. Transplant Proc. 2007;39:2736-9, doi: 10.1016/j.transproceed. 2007.08.078.
22. Guba M, von Breitenbuch P, Steinbauer M, Koehl G, Flegel S, Hornung M, et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med. 2002;8:128-35, doi: 10.1038/nm0202-128.
23. Campistol JM, Eris J, Oberbauer R, Friend P, Hutchison B, Morales JM, et al. Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation. J Am Soc Nephrol. 2006;17:581-9, doi: 10.1681/ASN.2005090993.
24. Krasagakis K, Fragiadaki I, Metaxari M, Kruger-Krasagakis S, Tzanakakis GN, Stathopoulos EN, et al. KIT receptor activation by autocrine and paracrine stem cell factor stimulates growth of merkel cell carcinoma in vitro. J Cell Physiol. 2011;226:1099-109, doi: 10.1002/jcp.22431.
25. Eng TY, Boersma MG, Fuller CD, Cavanaugh SX, Valenzuela F, Herman TS. Treatment of merkel cell carcinoma. Am J Clin Oncol. 2004;27:510-5, doi: 10.1097/01.coc.0000135567.62750.f4.
26. Bobos M, Hytiroglou P, Kostopoulos I, Karkavelas G, Papadimitriou CS. Immunohistochemical distinction between merkel cell carcinoma and small cell carcinoma of the lung. Am J Dermatopathol. 2006;28:99-104, doi: 10.1097/01.dad.0000183701.67366.c7.
27. Yiengpruksawan A, Coit DG, Thaler HT, Urmacher C, Knapper WK. Merkel cell carcinoma. Prognosis and management. Arch Surg. 1991;126:1514-9.
28. Allen PJ, Zhang ZF, Coit DG. Surgical management of Merkel cell carcinoma. Ann Surg. 1999;229:97-105, doi: 10.1097/00000658-199901000-00013.
29. Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol. 2005;23:2300-9, doi: 10.1200/JCO.2005.02.329.
30. Pitale M, Sessions RB, Husain S. An analysis of prognostic factors in cutaneous neuroendocrine carcinoma. Laryngoscope. 1992;102:244-9, doi: 10.1288/00005537-199203000-00003.
31. Hitchcock CL, Bland KI, Laney RG, 3rd, Franzini D, Harris B, Copeland EM, 3rd. Neuroendocrine (Merkel cell) carcinoma of the skin. Its natural history, diagnosis, and treatment. Ann Surg. 1988;207:201-207, doi: 10.1097/00000658-198802000-00015.
32. Cotlar AM, Gates JO, Gibbs FA, Jr. Merkel cell carcinoma: combined surgery and radiation therapy. Am Surg. 1986;52:159-64.
33. Boyle F, Pendlebury S, Bell D. Further insights into the natural history and management of primary cutaneous neuroendocrine (Merkel cell) carcinoma. Int J Radiat Oncol Biol Phys. 1995;31:315-23, doi: 10.1016/0360-3016(93)E0110-R.
34. Queirolo P, Gipponi M, Peressini A, Disomma CF, Vecchio S, Raposio E, et al. Merkel cell carcinoma of the skin. Treatment of primary, recurrent, and metastatic disease: review of clinical cases. Anticancer Res. 1997;17:673-7.
35. Westgate SJ. Radiation therapy for skin tumors. Otolaryngol Clin North Am. 1993;26:295-309.
36. Bichakjian CK, Lowe L, Lao CD, Sandler HM, Bradford CR, Johnson TM, et al. Merkel cell carcinoma: critical review with guidelines for multidisciplinary management. Cancer. 2007;110:1-12, doi: 10.1002/cncr.22765.
37. Sibley RK, Dehner LP, Rosai J. Primary neuroendocrine (Merkel cell?) carcinoma of the skin. I. A clinicopathologic and ultrastructural study of 43 cases.Am J Surg Pathol. 1985;9:95-108, doi: 10.1097/00000478-198502000-00004.
38. Messina JL, Reintgen DS, Cruse CW, Rappaport DP, Berman C, Fenske NA, et al. Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol. 1997;4:389-95, doi: 10.1007/BF02305551.
39. Edge SB, Byrd DR, Compton CC. 30 Merkel Cell Carcinoma. In: Edge SB, Byrd DR, Compton CC, editors. AJCC CANCER STAGING MANUALSeventh Edition. Seventh ed. Chicago: Springer New York Dordrecht Heildelberg London. 2010;315-9.
40. Boyer JD, Zitelli JA, Brodland DG, D'Angelo G. Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation. J Am Acad Dermatol. 2002;47:885-92, doi: 10.1067/mjd.2002.125083.
41. Jabbour J, Cumming R, Scolyer RA, Hruby G, Thompson JF, Lee S. Merkel cell carcinoma: assessing the effect of wide local excision, lymph node dissection, and radiotherapy on recurrence and survival in earlystage disease-results from a review of 82 consecutive cases diagnosed between 1992 and 2004. Ann Surg Oncol. 2007;14:1943-52, doi: 10.1245/s10434-006-9327-y.
42. Gonzalez RJ, Padhya TA, Cherpelis BS, Prince MD, Aya-Ay ML, Sondak VK, et al. The surgical management of primary and metastatic Merkel cell carcinoma. Curr Probl Cancer. 2010;34:77-96, doi: 10.1016/j.currproblcancer.2010.02.003.
43. Warner RE, Quinn MJ, Hruby G, Scolyer RA, Uren RF, Thompson JF. Management of merkel cell carcinoma: the roles of lymphoscintigraphy, sentinel lymph node biopsy and adjuvant radiotherapy. Ann Surg Oncol. 2008;15:2509-18, doi: 10.1245/s10434-008-9983-1.
44. Fenig E, Lurie H, Klein B, Sulkes A. The treatment of advanced Merkel cell carcinoma. A multimodality chemotherapy and radiation therapy treatment approach. J Dermatol Surg Oncol. 1993;19:860-4.
45. Gollard R, Weber R, Kosty MP, Greenway HT, Massullo V, Humberson C. Merkel cell carcinoma: review of 22 cases with surgical, pathologic, and therapeutic considerations. Cancer. 2000;88:1842-51, doi: 10.1002/ (SICI)1097-0142(20000415)88:8,1842::AID-CNCR13.3.0.CO;2-P.
46. Lewis KG, Weinstock MA, Weaver AL, Otley CC. Adjuvant local irradiation for Merkel cell carcinoma. Arch Dermatol. 2006;142:693-700, doi: 10.1001/archderm.142.6.693.
47. Gillenwater AM, Hessel AC, Morrison WH, Burgess M, Silva EG, Roberts D, et al. Merkel cell carcinoma of the head and neck: effect of surgical excision and radiation on recurrence and survival. Arch Otolaryngol Head Neck Surg. 2001;127:149-154.
48. Meeuwissen JA, Bourne RG, Kearsley JH. The importance of postoperative radiation therapy in the treatment of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys. 1995;31:325-31, doi: 10.1016/0360-3016(94)E0145-A.
49. Rao NG. Review of the role of radiation therapy in the management of Merkel cell carcinoma. Curr Probl Cancer. 2010;34:108-17, doi: 10.1016/j. currproblcancer.2010.01.005.
50. Mortier L, Mirabel X, Fournier C, Piette F, Lartigau E. Radiotherapy alone for primary Merkel cell carcinoma. Arch Dermatol. 2003;139:1587-1590, doi: 10.1001/archderm.139.12.1587.
51. Veness M, Foote M, Gebski V, Poulsen M. The role of radiotherapy alone in patients with merkel cell carcinoma: reporting the Australian experience of 43 patients. Int J Radiat Oncol Biol Phys. 2010;78:703-9, doi: 10.1016/j.ijrobp.2009.08.011.
52. Hui AC, Stillie AL, Seel M, Ainslie J. Merkel Cell Carcinoma: 27-Year Experience at the Peter MacCallum Cancer Centre. Int J Radiat Oncol Biol Phys. 2010 12(ahead of print). Int J Radiat Oncol Biol Phys. 2011;80:1430-5. Epub 2010 Aug 12, doi: 10.1016/j.ijrobp.2010.04.061.
53. Mehrany K, Otley CC, Weenig RH, Phillips PK, Roenigk RK, Nguyen TH. A meta-analysis of the prognostic significance of sentinel lymph node status in Merkel cell carcinoma. Dermatol Surg. 2002;28:113-117;discussion 7, doi: 10.1046/j.1524-4725.2002.02901.x
54. Kokoska ER, Kokoska MS, Collins BT, Stapleton DR, Wade TP. Early aggressive treatment for Merkel cell carcinoma improves outcome. Am J Surg. 1997;174:688-93, doi: 10.1016/S0002-9610(97)00193-1.
55. Poulsen MG, Rischin D, Porter I, Walpole E, Harvey J, Hamilton C, et al. Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin? Int J Radiat Oncol Biol Phys. 2006 1;64(1):114-119, doi: 10.1016/j.ijrobp.2005.04.042.
56. Garneski KM, Nghiem P. Merkel cell carcinoma adjuvant therapy: current data support radiation but not chemotherapy. J Am Acad Dermatol. 2007;57:166-169, doi: 10.1016/j.jaad.2007.03.011.
57. Pacella J, Ashby M, Ainslie J, Minty C. The role of radiotherapy in the management of primary cutaneous neuroendocrine tumors (Merkel cell or trabecular carcinoma): experience at the Peter MacCallum Cancer Institute (Melbourne, Australia). Int J Radiat Oncol Biol Phys. 1988;14:1077-84, doi: 10.1016/0360-3016(88)90382-3.
58. Fenig E, Brenner B, Katz A, Rakovsky E, Hana MB, Sulkes A. The role of radiation therapy and chemotherapy in the treatment of Merkel cell carcinoma. Cancer. 1997;80:881-885, doi: 10.1002/(SICI)1097-0142(19970 901)80:5,881::AID-CNCR8.3.0.CO;2-O.
59. Tennvall J, Biorklund A, Johansson L, Akerman M. Merkel cell carcinoma: management of primary, recurrent and metastatic disease. A clinicopathological study of 17 patients. Eur J Surg Oncol. 1989;15:1-9.
60. Gupta AS HS, Levine EA. Successful treatment of in-transit metastases from Merkel's cell carcinoma with isolated hyperthermic limb perfusion. South Med J. 1998;91:4, doi: 10.1097/00007611-199810001-00002.
61. Olieman AF, Lienard D, Eggermont AM, Kroon BB, Lejeune FJ, Hoekstra HJ, et al. Hyperthermic isolated limb perfusion with tumor necrosis factor alpha, interferon gamma, and melphalan for locally advanced nonmelanoma skin tumors of the extremities: a multicenter study. Arch Surg. 1999;134:303-7, doi: 10.1001/archsurg.134.3.303.
62. Lampreave JL, Benard F, Alavi A, Jimenez-Hoyuela J, Fraker D. PET evaluation of therapeutic limb perfusion in Merkel's cell carcinoma. J Nucl Med. 1998;39:2087-90.
63. Helm KF, Billingsley EY, Zangwill BC, Schwartz RA. Localized limb cutaneous metastases. J Surg Oncol. 1998;67:261-4, doi: 10.1002/ (SICI)1096-9098(199804)67:4,261::AID-JSO10.3.0.CO;2-3.
64. Duprat JP, Domingues AL, Coelho EG, Leal RM, Nishinari K, Neves RI. Long-term response of isolated limb perfusion with hyperthermia and chemotherapy for Merkel cell carcinoma. Eur J Surg Oncol. 2009;35: 568-72.